ENGOT-EN9/LEAP-001: A PHASE 3 STUDY OF FIRST-LINE PEMBROLIZUMAB PLUS LENVATINIB COMPARED WITH CHEMOTHERAPY IN ADVANCED OR RECURRENT ENDOMETRIAL CANCER
Randall, L.; Marth, C.; Vulsteke, C.; Rubio, M. Jesus; Makker, V.; Braicu, I.; McNeish, I.; Madry, R.; Ayhan, A.; Hasegawa, K.; Wu, X.; Dutta, L.; Xu, C.; Keefe, S.; Lee, J.; Pignata, S. (2020)